Disclaimer: The analyst who wrote this piece owns shares of Strategy (MSTR).Strategy (MSTR) expects its convertible preferred ...

Although most stocks made forward progress in January, a few of them bucked the bigger trend for understandable reasons.

IN8bio, Inc. (NASDAQ:INAB), a biotechnology firm specializing in cancer therapies, has been granted an additional 180 days to comply with Nasdaq's minimum bid price rule, as per a recent SEC filing.

Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...

With hopes of a soft economic landing and a rebound in initial public offerings, Nasdaq’s stock market welcomed 162 new listings in the fourth quarter, up from 100 a year earlier. That helped ...

SAN ANTONIO, TX - bioAffinity Technologies, Inc. has been notified by The Nasdaq Stock Market LLC that it has not met the ...

On January 29, Nasdaq reported its fourth quarter and full year 2024 earnings. Nasdaq’s results reflected a year of strong financial and operational performance as well as strategic execution across ...

NEW YORK - Nuvini Group Limited (NASDAQ:NVNI), a prominent acquirer of B2B SaaS companies in Latin America with a market ...

DUBLIN - Brera Holdings PLC (NASDAQ:BREA), an international holding company currently valued at $8.27 million, has been notified by the Nasdaq that it has not complied with the annual meeting ...

BioAtla, Inc., a biotechnology firm specializing in biological products, received notice from The Nasdaq Stock Market on Tuesday that it is at risk of being delisted. Currently trading at $0.45, the ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), a molecular genetics diagnostic company, announced on Monday, that it has regained compliance with Nasdaq's continued listing requirements. The company ...

Alternus Clean Energy, Inc. (NASDAQ:ALCE), a company specializing in electric and other services, is currently facing ...